# Delivery of Yamani-15/5 Chemical Solution for PAD

> **NCT02539303** · PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Yamani-15/5 chemical solution

## Key facts

- **NCT ID:** NCT02539303
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-08
- **Primary completion:** 2022-08
- **Final completion:** 2023-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to enroll subjects
- **Last updated:** 2022-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02539303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02539303, "Delivery of Yamani-15/5 Chemical Solution for PAD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02539303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*